The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding

Area of Science:

• Cardiology
• Intensive Care Medicine
• Hematology

Background:

• Extracorporeal membrane oxygenation (ECMO) is vital for cardiac and respiratory failure but carries significant complication risks.
• Existing data on ECMO-related risk factors and outcomes, particularly for hemorrhage, are limited and inconsistent.

Purpose of the Study:

• To identify risk factors and predictors of hemorrhage and adverse events in ECMO patients.
• To assess the impact of these complications on patient mortality.

Main Methods:

• Retrospective review of 321 patients who received ECMO support at a tertiary university center over ten years.
• Analysis of patient data to identify risk factors for hemorrhage and associated outcomes.

Main Results:

• Hemorrhage occurred in 38% of patients, representing the most frequent and severe ECMO complication.
• Hemorrhage was linked to increased one-year mortality (51% vs. 35%).
• Key hemorrhage risk factors included disease severity, prolonged activated partial thromboplastin time, and lower C-reactive protein and procalcitonin levels.

Conclusions:

• Hemorrhage remains a primary ECMO complication associated with higher mortality.
• Lower inflammation markers may be linked to increased bleeding risk during ECMO, a novel finding requiring further investigation.
• Stricter anticoagulation monitoring is recommended, especially in non-hyperinflammatory ECMO patients.